News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel
Rese-cel is an experimental CAR T-cell therapy designed to “reset” the immune system in people with autoimmune diseases.
Sonura’s Novel NICU Technology Featured in the Philadelphia Inquirer
Now being tested in a clinical trial at Penn, the device aims to reduce infant stress, support bonding, and potentially improve growth and feeding for preterm babies.
Avisi Technologies Announces First Patient Implanted with Glaucoma Treatment Device in Clinical Trial
Avisi treated its first patient in a clinical trial to evaluate the safety and effectiveness of its novel VisiPlate® glaucoma treatment device.
BlueWhale Bio Raises $5M, Partners with Avantor, Inc.
BlueWhale Bio was co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy and James Riley, PhD, Professor of Microbiology, both at Penn Medicine.
PCI Hosts 10th Annual Celebration of Innovation
On December 2, PCI celebrated Penn researchers and innovators named as inventors on patents issued to Penn this past fiscal year.
University of Pennsylvania Launches StartUP Fund
Penn announced the launch of its StartUP Fund.
Vital Start Health Expands Virtual Mental Health Platform
Vital Start Health is co-founded by John Chuo, MD, MSBI, Chief Scientific Officer, Professor of Clinical Pediatrics at Penn Medicine, and Neonatal Quality Officer at CHOP.
Tom Logan Joins the Office of the Chief Innovation Officer
Tom Logan, PhD, was hired as Senior Executive Director in the Office of Innovation.
Vasowatch Earns National Recognition for Breakthrough Research and Innovation in Preventing Postpartum Hemorrhage
Vasowatch aims to improve maternal health outcomes with postpartum hemorrhage risk prediction technology.
Cogwear Named one of the Top Startups to Watch in 2025 by the Philadelphia Business Journal
Cogwear was recognized for its growth, funding and future projections.